These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1015 related items for PubMed ID: 20597992

  • 1. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 2. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
    Ludka O, Spinar J, Tomandl J, Konecny T.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
    [Abstract] [Full Text] [Related]

  • 3. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D.
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [Abstract] [Full Text] [Related]

  • 4. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
    Nakatani T, Naganuma T, Masuda C, Uchida J, Sugimura T, Sugimura K.
    Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
    [Abstract] [Full Text] [Related]

  • 5. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    Nephron Clin Pract; 2009 Oct; 111(3):c182-8. PubMed ID: 19194108
    [Abstract] [Full Text] [Related]

  • 6. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 7. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A, Güz G, Mutluay R, Okyay K, Demirtaş C, Paşaoğlu H, Yalçın R.
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [Abstract] [Full Text] [Related]

  • 8. Relationships between brain natriuretic peptide, troponin I and QT dispersion in asymptomatic dialysis patients.
    Taskapan MC, Taskapan H, Ulutas O, Orhan M, Sahin I.
    Ren Fail; 2007 Sep; 29(2):221-5. PubMed ID: 17365940
    [Abstract] [Full Text] [Related]

  • 9. Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers.
    Codognotto M, Piccoli A, Zaninotto M, Mion MM, Ruzza L, Barchita A, Naso A, Plebani M.
    J Nephrol; 2010 Sep; 23(4):465-71. PubMed ID: 20540041
    [Abstract] [Full Text] [Related]

  • 10. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.
    Kidney Blood Press Res; 2009 Sep; 32(5):373-9. PubMed ID: 19887825
    [Abstract] [Full Text] [Related]

  • 11. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B, Bakri RS, Bharma-Ariza P, Lumb PJ, Dalton N, Turner NC, Wierzbicki AS, Crook MA, Goldsmith DJ.
    J Nephrol; 2003 Sep; 16(4):540-5. PubMed ID: 14696756
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q, Bárány P, Qureshi AR, Snaedal S, Heimburger O, Stenvinkel P, Lindholm B, Axelsson J.
    Am J Nephrol; 2009 Sep; 29(6):516-23. PubMed ID: 19077418
    [Abstract] [Full Text] [Related]

  • 13. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J, Králová H, Trefil L, Rajdl D, Eiselt J.
    Nephron Clin Pract; 2006 Sep; 103(4):c162-72. PubMed ID: 16645318
    [Abstract] [Full Text] [Related]

  • 14. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M.
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [Abstract] [Full Text] [Related]

  • 15. Influence of intraperitoneal volume on QT dispersion in patients with continuous ambulatory peritoneal dialysis: acute cardiac impact of peritoneal dialysis.
    Kocak G, Azak A, Huddam B, Yalcin F, Güven B, Can M, Duranay M.
    Ren Fail; 2011 May; 33(6):568-71. PubMed ID: 21631168
    [Abstract] [Full Text] [Related]

  • 16. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G, Corrado E, Mulè MC, Augugliaro S, Cucchiara A, Novo G, Amoroso G, Assennato P, Hoffmann E, Vitale F, Novo S.
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of plasma myeloperoxidase in ESRD patients.
    Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE.
    Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B, Supasyndh O, Phantana-Angkul P, Ruangkanchanasetr P, Nata N, Chaiprasert A, Kanjanakul I, Choovichian P.
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [Abstract] [Full Text] [Related]

  • 19. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 20. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, Oh HY, Kim YG.
    Nephron Clin Pract; 2008 Oct; 110(2):c93-100. PubMed ID: 18815449
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.